📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Comparative review of pharmacological therapies in individuals with HER2-positive advanced breast cancer with focus on hormone receptor subgroups. (2022)

First Author: Umemneku-Chikere CM

Attributed to: HCD: Novel approaches of multi-parameter evidence synthesis and decision modelling for efficient evaluation of diagnostic health technologies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fonc.2022.943154

PubMed Identifier: 36059633

Publication URI: http://europepmc.org/abstract/MED/36059633

Type: Journal Article/Review

Volume: 12

Parent Publication: Frontiers in oncology

ISSN: 2234-943X